IL15 and viral infectious disease: Since viral sequences are largely identical to the challenge stock at this early timepoint, protection vs. non-protection is more likely related to the functional capacity of the SIV-specific T cells in the early sites of viral infection, a conclusion supported by the correlation of efficacy with the level of activity of the effector-functional promoting cytokine IL-15 (12).